User login
Article Type
Changed
Tue, 05/03/2022 - 16:02
Display Headline
Comparing Antithrombotic Regimens for Diabetic Patients Undergoing PCI
Article PDF
Issue
Federal Practitioner - 27(1)
Publications
Topics
Page Number
32
Legacy Keywords
diabetes, antithrombotic, PCI, percutaneous coronary interventions, bivalirudin, tirofiban, unfractionated heparin, platelet glycoprotein inhibitor, myocardial infarctiondiabetes, antithrombotic, PCI, percutaneous coronary interventions, bivalirudin, tirofiban, unfractionated heparin, platelet glycoprotein inhibitor, myocardial infarction
Sections
Article PDF
Article PDF
Issue
Federal Practitioner - 27(1)
Issue
Federal Practitioner - 27(1)
Page Number
32
Page Number
32
Publications
Publications
Topics
Article Type
Display Headline
Comparing Antithrombotic Regimens for Diabetic Patients Undergoing PCI
Display Headline
Comparing Antithrombotic Regimens for Diabetic Patients Undergoing PCI
Legacy Keywords
diabetes, antithrombotic, PCI, percutaneous coronary interventions, bivalirudin, tirofiban, unfractionated heparin, platelet glycoprotein inhibitor, myocardial infarctiondiabetes, antithrombotic, PCI, percutaneous coronary interventions, bivalirudin, tirofiban, unfractionated heparin, platelet glycoprotein inhibitor, myocardial infarction
Legacy Keywords
diabetes, antithrombotic, PCI, percutaneous coronary interventions, bivalirudin, tirofiban, unfractionated heparin, platelet glycoprotein inhibitor, myocardial infarctiondiabetes, antithrombotic, PCI, percutaneous coronary interventions, bivalirudin, tirofiban, unfractionated heparin, platelet glycoprotein inhibitor, myocardial infarction
Sections
Article Source
PURLs Copyright
Inside the Article
Article PDF Media
Document